Raptor Pharm (RPTP) Misses Q4 EPS by 10c

Raptor Pharm (NASDAQ: RPTP) reported Q4 EPS of ($0.37), $0.10 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Royal Unibrew reports higher interim first-half profit as margins improve